Pre-therapeutic Analysis of the Individual Radiosensitivity of Cancer Patients in Luxembourg (APRI-Lux): Prospective National Interventional Study With Minimal Risk

Centre Francois Baclesse, Luxembourg

Status: Not yet enrolling

Conditions: Radiation Toxicity; Radiosensitivity; Cancer

Treatments: Biological: Blood sample collection

Study type: Interventional

Funder types: Other; Industry

Identifiers

NCT05433974

APRI-Lux

Details and patient eligibility

About

Pre-therapeutic analysis of the individual radiosensitivity of cancer patients in Luxembourg

Enrollment: 200 estimated patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Patient over 18 years old
• Patient with an indication for curative radiotherapy
• Patient having given his signed written informed consent before any specific procedure of the protocol.

Exclusion criteria

• Patient with a contraindication to radiotherapy
• Patient with an indication for palliative radiotherapy
• Patient with a history of radiotherapy in the area where the cancer is located
• Patient unable to submit to the medical follow-up of the trial for geographical, social or psychological reasons.

Trial design

Primary purpose: Health Services Research

Allocation: N/A

Interventional model: Single Group Assignment

Masking: None (Open label)

---

200 participants in 1 patient group

Radiosensitivity

Other group

Description:

Patient who agree to participate in this research study will have blood sample collected in order to perform the RadioDtect test.

Treatment:

Biological: Blood sample collection